MS drugs in Medicare Part D: Higher tiers, less coverage, more prior authorizationsApril 27, 2018Multiple Sclerosis
VIDEO: AAN MS guidelines aim to help clinicians weigh expanding drug choicesApril 24, 2018Multiple Sclerosis
Blood-brain barrier health may signal early loss of MS treatment responseApril 20, 2018Multiple Sclerosis
Frankincense extract may reduce disease activity in relapsing-remitting MSMarch 27, 2018Multiple Sclerosis
Siponimod trial ‘first’ to show delayed disability in secondary progressive MSMarch 22, 2018Multiple Sclerosis
MRI finds PML in some natalizumab-treated patients despite negative CSF, no symptomsMarch 20, 2018Multiple Sclerosis
The case for being open-minded about medical marijuanaMarch 9, 2018PainMultiple SclerosisNeuromuscular Disorders
Researchers find predictors of worse MS outcomes in post hoc study of three trialsFebruary 28, 2018Multiple Sclerosis
Fingolimod switch from an injectable linked to improved outcomes in relapsing MSFebruary 26, 2018Multiple Sclerosis
